112 related articles for article (PubMed ID: 26044202)
21. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
[TBL] [Abstract][Full Text] [Related]
22. Formulation of sustained-release microspheres of granulocyte macrophage colony stimulating factor by freezing-induced phase separation with dextran and encapsulation with blended polymers.
Zhang XR; Zheng Y; Jin T; Chow AH
J Microencapsul; 2011; 28(8):743-51. PubMed ID: 21967463
[TBL] [Abstract][Full Text] [Related]
23. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
24. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
25. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
Int J Pharm; 2012 May; 427(2):299-304. PubMed ID: 22366485
[TBL] [Abstract][Full Text] [Related]
26. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
Lu J; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
[TBL] [Abstract][Full Text] [Related]
27. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
28. The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres.
Guo X; Dong C; Liu Q; Zhu X; Zuo S; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108823. PubMed ID: 30965238
[TBL] [Abstract][Full Text] [Related]
29. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
30. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
[TBL] [Abstract][Full Text] [Related]
31. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
[TBL] [Abstract][Full Text] [Related]
32. Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats.
D'Souza M; DeSouza P
Drug Dev Ind Pharm; 1998 Sep; 24(9):841-52. PubMed ID: 9876535
[TBL] [Abstract][Full Text] [Related]
33. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
Zhang H; Gao Y; Lv W; Jiao C; Duan M; Liu H; Han B
J Pharm Sci; 2011 Jul; 100(7):2790-800. PubMed ID: 21344412
[TBL] [Abstract][Full Text] [Related]
34. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
35. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
Nandakumar V; Geetha V; Chittaranjan S; Doble M
Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
[TBL] [Abstract][Full Text] [Related]
36. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
[TBL] [Abstract][Full Text] [Related]
37. Microspheres prepared with different co-polymers of poly(lactic-glycolic acid) (PLGA) or with chitosan cause distinct effects on macrophages.
Bitencourt Cda S; Silva LB; Pereira PA; Gelfuso GM; Faccioli LH
Colloids Surf B Biointerfaces; 2015 Dec; 136():678-86. PubMed ID: 26497115
[TBL] [Abstract][Full Text] [Related]
38. Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.
Wang H; Su W; Wang S; Wang X; Liao Z; Kang C; Han L; Chang J; Wang G; Pu P
Nanoscale; 2012 Oct; 4(20):6501-8. PubMed ID: 22961067
[TBL] [Abstract][Full Text] [Related]
39. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
Kim HK; Park TG
J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
[TBL] [Abstract][Full Text] [Related]
40. Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.
Arai T; Benny O; Joki T; Menon LG; Machluf M; Abe T; Carroll RS; Black PM
Anticancer Res; 2010 Apr; 30(4):1057-64. PubMed ID: 20530409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
